Non-pharmacological treatment of hereditary spastic paraplegia: a systematic review.
Simona Maccora, Angelo Torrente, Vincenzo Di Stefano...
https://pubmed.ncbi.nlm.nih.gov/37968432/Actively Recruiting
Led by IRCCS Eugenio Medea · Updated on 2025-01-30
20
Participants Needed
2
Research Sites
17 weeks
Total Duration
Hereditary Spastic Paraplegia HSP is a group of inherited neurological conditions causing progressive weakness and stiffness in the lower limbs, which greatly reduce walking ability and balance. This research aims to evaluate the feasibility and effectiveness of a structured training program designed to improve walking function in adults with HSP by focusing on flexibility, muscle strength, motor control, balance, and aerobic fitness. Participants will take part in 10 to 16 therapy sessions lasting between 60 and 120 minutes each, held once or twice a week according to individual preference. The program includes four key components flexibility exercises combined with electrical stimulation to reduce muscle tone resistance training targeting hip and trunk muscles along with balance exercises motor control-based gait training and high-intensity interval aerobic training using activities like walking or cycling. After completing the supervised sessions, participants will receive written and video materials to support continued exercise at home. Evaluations will be conducted before the program starts, immediately after it ends 5 to 10 weeks later, and three months after completion. Researchers will assess the feasibility by tracking recruitment, adherence to the sessions, participant retention, safety, and satisfaction. They will also measure changes in walking endurance and speed using standardized walking tests, as well as improvements in muscle strength, balance, and joint mobility.
CONDITIONS
Flexibility, Resistance, Aerobic, Movement Execution Training in Adults With Hereditary Spastic Paraplegia
L
Leonardo Boccuni, PhD
M
Marco Bortolini, BSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
IRCCS Eugenio Medea
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 5 to 10 weeks
Participants receive a comprehensive neurorehabilitation program consisting of flexibility, resistance, movement execution, and aerobic training to improve gait capacity. The program includes 10 to 16 therapist-guided sessions lasting 60 to 120 minutes each, conducted once or twice weekly based on individual preference and capability.
10 to 16 treatment sessions over 5 to 10 weeks
Duration - 12 weeks
Participants are evaluated 12 weeks after completing the treatment to assess sustained improvements in walking endurance and speed.
1 follow-up visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Simona Maccora, Angelo Torrente, Vincenzo Di Stefano...
https://pubmed.ncbi.nlm.nih.gov/37968432/Jennifer Crozier, Marc Roig, Janice J Eng...
https://pubmed.ncbi.nlm.nih.gov/29676956/Marta Bellofatto, Giovanna De Michele, Aniello Iovino...
https://pubmed.ncbi.nlm.nih.gov/30723448/Liselot Thijs, Eline Voets, Stijn Denissen...
https://pubmed.ncbi.nlm.nih.gov/36864008/Janice J Eng, Pei-Fang Tang
https://pubmed.ncbi.nlm.nih.gov/17939776/Leonardo Boccuni, Marco Bortolini, Cristina Stefan...
https://pubmed.ncbi.nlm.nih.gov/40040914/Luis Ruano, Claudia Melo, M Carolina Silva...
https://pubmed.ncbi.nlm.nih.gov/24603320/IRCCS Eugenio Medea
Lead Sponsor